Valorant Champions Tour 2022 EMEA Stage 1 Challengers is scheduled in World from 11.02.2022 to 27.03.2022. Valorant Champions Tour 2022 EMEA Stage 1 Challengers features 33 Valorant teams across the globe competing for a cash fund of $220,000.
This competition is going to be split into 6 parts:
- Playoffs (World): 22.03.2022 – 27.03.2022. 6 Teams.
- Group A (World): 11.02.2022 – 13.03.2022. 6 Teams.
- Group B (World): 11.02.2022 – 13.03.2022. 6 Teams.
- Europe Closed Qualifier #2 Playoffs (World): 20.01.2022 – 23.01.2022. 8 Teams.
- CIS Closed Qualifier #2 Playoffs (World): 20.01.2022 – 23.01.2022. 8 Teams.
- Turkey Closed Qualifier #2 Playoffs (World): 20.01.2022 – 22.01.2022. 8 Teams.
Make sure to consult our betting advice and suggestions about the potential champion of each phase of Valorant Champions Tour 2022 EMEA Stage 1 Challengers prior to making your own selections and picking the favorites. At our website, we continuously refresh our collection of forecasts, so coming back to this site to get fresh recommendations is perpetually a smart strategy.
An online series organized by Riot Games, Champions Tour 2022 is an A-tier tournament and the first series in the highest-level competitive Valorant Circuit. Opening its doors for challengers from the Europe, CIS, and Turkey regions, the series features 12 competitors battling it out for the total prize pool of €200 000 in a Double Elimination format. And, of course, one more thing - the ability to advance to the later brackets of the Valorant pro circuit, including the World Championship later, is also at stake.
The teams are divided into 2 groups for the event's Group Stage. We see a lot of familiar faces competing in the series, including Acend, Gambit Esports, Team Liquid, Fnatic, Guild Esports, BIG, SuperMassive Blaze, FunPlus Phoenix, G2 Esports, LDN UTD, BBL Esports, and Natus Vincere. The analysts have pointed out Gambit Esports as the main favorites of the event due to their deep understanding of the meta, yet Acend are proving to be their match with their early performance.